Overview

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of long-term therapy with rosuvastatin compared with a placebo, and to evaluate whether treatment with rosuvastatin might be effective in reducing the risk of major cardiovascular events.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rosuvastatin Calcium